Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2010-12-15. The firm operates in four business segments. The Medical Business segment produces and sells therapeutic drugs and infusions. The Nutraceutical segment produces and sells functional beverages, quasi-drugs and nutritional supplements. The Consumer Products segment produces and sells mineral water, beverages and food products. The Others segment manufactures paper containers, manufactures synthetic resin molded products, stores products, provides storage space, and produces and sells chemicals and liquid crystal evaluation equipment, spectroscopic analysis equipment, and other products.
Otsuka Holdings Co Ltd 주요 수익원은 Pharmaceuticals이며, 최신 수익 발표에서 수익은 1,744,234,000,000입니다. 지역별로는 Japan이 Otsuka Holdings Co Ltd의 주요 시장이며, 수익은 718,100,000,000입니다.
Otsuka Holdings Co Ltd은 수익성이 있나요?
예, 최신 재무제표에 따르면 Otsuka Holdings Co Ltd의 순이익은 $343,120입니다.